ribavirin has been researched along with Hematologic Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 14 (53.85) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Adjallé, R; Ayuk, F; Bokemeyer, C; Fiedler, W; Ghandili, S; Kröger, N; Lindhauer, C; Modemann, F; Pischke, S; Polywka, S; Von Kroge, PH; Zur Wiesch, JS | 1 |
| Fazylov, VKh; Manapova, ÉR; Sozinova, IuM; Tkacheva, SV | 1 |
| Abbas, SM; El-Feky, HM; Hegab, MF; Lashin, AH; Metwally, MA; Shaheen, YA | 1 |
| Cornberg, M; Deterding, K; Höner Zu Siederdissen, C; Maasoumy, B; Manns, MP; Markova, AA; Port, K; Rogalska-Taranta, M; Wedemeyer, H | 1 |
| Cheng, HS; Hung, CH; Hung, IW; Hwang, JJ; Lin, CH; Lo, CC; Tsai, WJ | 1 |
| Clemente-Ricote, G; García-González, X; Giménez-Manzorro, Á; Ochoa-Palominos, A; Rodríguez-González, CG; Sanjurjo-Sáez, M | 1 |
| Arenas, J; Cheinquer, H; Dong, Y; Flisiak, R; Nikitin, I; Rana, K; Shiffman, M; Srinivasan, S | 1 |
| Alba, LM; Bulchandani, D; Nachnani, JS; Pandya, PK; Rao, GA | 1 |
| Chayama, K; Hayashi, N; Kumada, H; Okanoue, T; Toyota, J; Tsubouchi, H | 1 |
| Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kotoh, K; Maruyama, T; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y | 1 |
| Baek, S; Choi, SH; Kim, DY; Kim, MN; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Park, SY; Sung, H; Woo, JH | 1 |
| Fried, MW; Russo, MW | 1 |
| Dieterich, DT; Spivak, JL | 1 |
| Aspinall, RJ; Pockros, PJ | 1 |
| Keeffe, EB; Kowdley, KV | 1 |
| Fredrick, RT; Hassanein, TI | 1 |
| Kowdley, KV | 1 |
| Collantes, RS; Younossi, ZM | 1 |
| Arizcorreta, A; Brun, F; Fernández-Gutiérrez, C; García Juárez, R; Girón-González, JA; Guerrero, F; Pérez-Guzmán, E | 1 |
| Blanco, JL; Forns, X; García, F; Gatell, JM; Laguno, M; Larrousse, M; León, A; Loncá, M; Mallolas, J; Martínez, E; Milinkovic, A; Miró, JM; Murillas, J; Sánchez-Tapias, JM | 1 |
| Sulkowski, MS | 1 |
| Behler, CM; Chung, RT; Lin, F; Peters, MG; Robbins, GK; Vittinghoff, E; Volberding, PA | 1 |
| Fischer, K; Griffioen, A; Makris, M; Mauser-Bunschoten, EP; Posthouwer, D; Van Veen, JJ; Yee, TT | 1 |
| Decker, M; Fluckiger, U; Gratwohl, A; Halter, J; Heim, D; Hirsch, HH; Khanna, N; Steffen, I; Weisser, M; Widmer, AF | 1 |
| Boudreaux, MK; Cox, NR; Weiss, RC | 1 |
| Kawabe, T; Toda, G | 1 |
8 review(s) available for ribavirin and Hematologic Diseases
| Article | Year |
|---|---|
Side effects of therapy for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Mental Disorders; Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2003 |
The management of side-effects during therapy for hepatitis C.
Topics: Antiviral Agents; Depressive Disorder; Drug Carriers; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2004 |
Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplantation.
Topics: Antiviral Agents; Growth Substances; Hematologic Diseases; Hematopoiesis; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin; United States | 2005 |
Hematologic side effects of interferon and ribavirin therapy.
Topics: Anemia, Hypochromic; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2005 |
The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin.
Topics: Anemia, Hypochromic; Antiviral Agents; Darbepoetin alfa; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematinics; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2005 |
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].
Topics: Abnormalities, Drug-Induced; Antiviral Agents; Biopsy; Comorbidity; Disease Progression; Female; Hematologic Diseases; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver; Male; Ribavirin | 2005 |
Management of the hematologic complications of hepatitis C therapy.
Topics: Anemia; Antiviral Agents; Bone Marrow; Epoetin Alfa; Erythropoietin; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon Type I; Neutropenia; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2005 |
[Treatment of chronic hepatitis C patients complicated with the other disease].
Topics: Collagen Diseases; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Ribavirin | 2001 |
6 trial(s) available for ribavirin and Hematologic Diseases
| Article | Year |
|---|---|
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Protease Inhibitors; Ribavirin; Risk Assessment; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Young Adult | 2016 |
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Japan; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult | 2012 |
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
Topics: Adult; Age Factors; Antiviral Agents; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Sex Factors | 2012 |
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematologic Diseases; Hemorrhage; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2004 |
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
Topics: Adult; Antiviral Agents; Hematologic Diseases; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Maximum Tolerated Dose; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
12 other study(ies) available for ribavirin and Hematologic Diseases
| Article | Year |
|---|---|
Clinical features of hepatitis E infections in patients with hematologic disorders.
Topics: Antiviral Agents; Hematologic Diseases; Hepatitis E; Hepatitis E virus; Humans; Retrospective Studies; Ribavirin; Treatment Outcome | 2022 |
[Pegylated intereferon hematological safety in comparison with standard].
Topics: Adult; Antiviral Agents; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2012 |
Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.
Topics: Adolescent; Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Egypt; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Thrombocytopenia; Young Adult | 2013 |
Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy.
Topics: Adult; Aged; Anemia; Antiviral Agents; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hematologic Diseases; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrophosphatases; Retrospective Studies; Ribavirin; Taiwan; Thrombocytopenia | 2015 |
[Cost-effectiveness and safety of telaprevir and boceprevir for chronic hepatitis C in real-world clinical practice].
Topics: Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hematologic Diseases; Hepatitis C, Chronic; Hospitalization; Humans; Interferons; Male; Middle Aged; Oligopeptides; Proline; Protease Inhibitors; Remission Induction; Retrospective Studies; Ribavirin; Spain | 2015 |
Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
Topics: Adult; Anemia; Antiviral Agents; Female; Genotype; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Multivariate Analysis; Neutropenia; Ribavirin; Risk Factors; Thrombocytopenia | 2010 |
Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Female; Hematologic Diseases; Humans; Male; Middle Aged; Paramyxoviridae; Paramyxoviridae Infections; Propensity Score; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome | 2013 |
Hematologic disorders associated with hepatitis C virus infection and their management.
Topics: Antiviral Agents; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukin-11; Recombinant Proteins; Ribavirin; United States | 2003 |
Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
Topics: Antiviral Agents; Drug Therapy, Combination; Growth Substances; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; United States | 2005 |
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cohort Studies; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferons; International Cooperation; Male; Middle Aged; Ribavirin; Treatment Outcome | 2007 |
Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Topics: Adult; Cell Culture Techniques; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin | 2008 |
Toxicologic effects of ribavirin in cats.
Topics: Administration, Oral; Animals; Blood Cells; Blood Chemical Analysis; Bone Marrow; Cats; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Injections, Intramuscular; Injections, Intravenous; Male; Random Allocation; Ribavirin; Specific Pathogen-Free Organisms | 1993 |